Detected ·
Kinvard Bio
——
Kinvard Bio has joined the PACE portfolio, receiving funding to help advance its development of next-generation antibiotics (Oxepanoprolinamides) for serious Gram-negative infections.
- Website
- www.kinvardbio.com
- linkedin.com/company/105666234
- Amount
- —
- Stage
- —
- Event
- Funding round
- Detected
- 2026-11-20 00:07:10 UTC
- Signal ID
- 096a0508-a730-44a0-9410-537d73cd95ad
As the API returns it
{
"id": "096a0508-a730-44a0-9410-537d73cd95ad",
"created_at": "2026-11-20T00:07:10.294395Z",
"company_name": "Kinvard Bio",
"company_website_url": "www.kinvardbio.com",
"company_linkedin_url": "https://www.linkedin.com/company/105666234",
"event_type": "funding",
"funding_amount": null,
"funding_currency": null,
"funding_stage": null,
"message": "*Kinvard Bio has joined the PACE portfolio, receiving funding to help advance its development of next-generation antibiotics (Oxepanoprolinamides) for serious Gram-negative infections.*"
}